ATOVAQUONE

Post-LOE

atovaquone

ANDAORALSUSPENSION
Approved
Oct 2021
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
4

Mechanism of Action

12.1 Mechanism of Action Atovaquone is a quinone antimicrobial drug [ see Microbiology ] . 12.2 Pharmacodynamics Relationship between Plasma Atovaquone Concentrations and Clinical Outcome In a comparative clinical trial, HIV/AIDS subjects received atovaquone tablets 750 mg 3 times daily or TMP-SMX…

Pharmacologic Class:

Antimalarial

Clinical Trials (4)

NCT04648033Phase 1Completed

Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC

Started Dec 2020
21 enrolled
Locally Advanced Non-Small Cell Lung Cancer
NCT01858831Phase 1Completed

Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension

Started Apr 2012
30 enrolled
Malaria
NCT00084227Phase 2/3Completed

Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America

Started Jul 2004
244 enrolled
Malaria, Falciparum
NCT00000802Phase 3Completed

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides